1. Home
  2. Browse
  3. Bone & Joint
  4. Rheumatoid Arthritis
  5. Drug Toxicity

Drug Toxicity

16 - 30 of 32 Results
Sort Results:
Article: Recent warnings about acetaminophen will bring up more questions about serious drug-induced skin reactions October 2013
Article: new ORAL agent for rheumatoid arthritis, Xeljanz (ZEL-jans, tofacitinib) January 2013
Article: PPIs with methotrexate can lead to methotrexate toxicity December 2012
Commentary: Proton Pump Inhibitor-Methotrexate Interaction December 2012
Article: monitoring the aggressive drug regimens your patients are taking for rheumatoid arthritis July 2012
Guideline: 2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis July 2012
Guideline: Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs (2011) July 2012
Other: FDA Approves New Drug for Rheumatoid Arthritis March 2010
Article: new IV biologic for rheumatoid arthritis called Actemra (ack-TEM-rah) March 2010
Article: limiting the use of piroxicam (Feldene, etc) August 2009
Commentary: Safety of Piroxicam August 2009
Patient Education: What I Need to Know About My Rheumatoid Arthritis Medication August 2009
Article: Simponi (SIM-po-nee), a new tumor necrosis factor (TNF) blocker for rheumatoid arthritis June 2009
Guideline: Use of Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (2008) June 2009
Commentary: Simponi (Golimumab): A Monthly Injectable Drug for Arthritis June 2009